Together we go further faster. We value collaboration vs competition. We reach out to potential partners worldwide who share our values and commitment to global health. Our innovative business model is based on fairness and an appreciation of all the stakeholders taking part in effectively developing innovative therapeutic solutions. Each partner brings unique contributions to the development process. Click or tap an image below to read more on how we connect with our partners.
How we work together
The pharmaceutical industry
Partnering with pharma to design new therapeutic solutions.
We already work with several large pharmas and a range of smaller entities worldwide. They share our vision for the global transformation of the pharmaceutical industry. We create long-term alliances with our partners based on a multi-product agreement and profit sharing. Our flexible business model allows us to stay innovative and make a large amount of best-in-class products with a very high likelihood of success.
Partnering with health practitioners to pinpoint unmet needs.
We work with a variety of health practitioners because they’re in touch with their patients and aware of the limitations of current treatment. Our practitioners are convinced that LAI could be a game changer in their therapeutic area of expertise. Health practitioners are essential to our success, so we make sure they’re fully integrated, from API screening to deployment. More directly, practitioners help us in designing the TPP (Target Product Profile). Are you a health practitioner interested in partnering in our vision?
Foundations & NGOs
Partnering with foundations & NGOs to meet the needs of the many.
We’re currently collaborating with foundations and NGOs to develop best-in-class, cost effective products based on BEPO®. Thanks to BEPO’s flexibility and affordability, we’re able to quickly develop therapeutic solutions responding to health needs worldwide. To foundations and NGOs, we offer full access to our technology and valuable network.
Partnering with biotech companies to engineer solutions.
We believe in collaboration vs competition. In the same vein, a large amount of biotech companies develop APIs that can’t be used with traditional drug delivery systems. In addition, toxicity levels can overpower the benefits. We’re coming with the solution. Our technology becomes the empowering entity to APIs.
Contract research organizations
Partnering with CROs to find the best solutions.
CROs provide us with multiple services ranging from preclinical to clinical studies. By efficiently using their expertise, we are able to optimize costs. Finance aside, CROs help us to develop products more rapidly.
Market access companies
Partnering with market access companies to better understand and anticipate the market.
A large part of staying on the cutting-edge is in identifying current and foreseeable trends and competitors. Partnering with market access companies gives us the assurance that patients, physicians and payers will have what they need.
Partnering with academics in their field of research.
Let’s take it back to the beginning. MedinCell was founded by a group of academics with higher health related standards. We haven’t skipped a beat since then. We currently collaborate with universities from all over the world to dream up future technologies encompassing New Therapeutic Solutions. Are you an academic?